Individual Patient Expanded Access Applications: Form FDA 3926
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 3, 2017
January 29, 2024
6de5fa70-12b9-446e-a760-cc6dd4a4cb1d
Related Documents
Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification Guidance for Industry
Guidance DocumentJune 3, 2021Center for Drug Evaluation and Research
Formal Dispute Resolution: Sponsor Appeals Above the Division Level Guidance for Industry and Review Staff
Guidance DocumentMay 30, 2019Center for Drug Evaluation and Research
Tropical Disease Priority Review Vouchers
Guidance DocumentOctober 6, 2016Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox